RA Capital Management, L.P. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
RA Capital Management, L.P. | 0 0.000% |
-4,398,453 (Position Closed) |
Filing |
| 2022-04-25 4:30 pm Purchase |
2022-04-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
RA Capital Management, L.P. | 4,398,453 7.100% |
4,398,453 (New Position) |
Filing |